Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 76 Neoplasm Metastasis 13 Stomach Neoplasms 12 Neoplasms 8 Breast Neoplasms, Male 8 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 6 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Ovarian Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Squamous Cell Carcinoma of Head and Neck 3 Inflammatory Breast Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Vulvar Neoplasms 2 Vipoma 2 Vaginal Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Urethral Neoplasms 2 Thyroid Neoplasms 2 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Testicular Neoplasms 2 Somatostatinoma 2 Solid Tumor 2

Interventions

Nivolumab 8 Paclitaxel 6 Sirolimus 5 Bevacizumab 5 temsirolimus 4 Pemetrexed 4 Ipilimumab 4 Docetaxel 4 Carboplatin 4 ARRY-334543 4 Gemcitabine 3 Erlotinib Hydrochloride 3 olaparib 2 linrodostat 2 apatinib 2 anlotinib 2 abemaciclib 2 Vorinostat 2 Sunitinib 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Everolimus 2 Doxorubicin 2 Dasatinib 2 Chlorogenic Acid 2 Cetuximab 2 6-(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-ylsulfanyl)quinoline 2 vorolanib 1 vistusertib 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Cancer × Trastuzumab × Clear all

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡